Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-04-17
2007-04-17
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007920, C435S007930, C435S810000, C435S961000, C435S975000, C436S524000, C436S527000, C436S056000, C436S815000, C530S389800, C530S405000, C530S406000, C530S811000
Reexamination Certificate
active
11345706
ABSTRACT:
Novel conjugates of 5-fluoro-uracil and novel 5-fluoro-uracil immunogens and monoclonal antibodies generated by these immunogens which are useful in immunoassays for the quantification and monitoring of 5-fluoro-uracil in biological fluids.
REFERENCES:
patent: 3996344 (1976-12-01), Gross
patent: 4016146 (1977-04-01), Soares
patent: 4269511 (1981-05-01), Erwin
patent: 4420568 (1983-12-01), Wang et al.
patent: 5101015 (1992-03-01), Byrnes et al.
patent: 5501987 (1996-03-01), Ordonez et al.
patent: 363222699 (1988-09-01), None
patent: 363222699 (1988-09-01), None
patent: 411337549 (1999-10-01), None
patent: 411337549 (1999-12-01), None
Bird et al., Single-Chain Antigen-Binding Proteins, Science, 242: 423-426 (1988).
Coligan, J.E. et al., eds., Current Protocols in Immunology, 2.5.1-2.5.17, (1992), Wiley & Sons, NY.
Dasio et al., Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity, J. Clin Invest, Jan. 1988; 81(1): 47-51.
Escoriaza et al., Simple and sensitive determination of 5 -fluorouracil in plasma by high -per-formance liquid chromatography: Application to clinical pharmacokinetic studies, Journal of Chromatography B: Biomedical Sciences and applications, 736 (1+2): pp. 97-102, 1999.
Hon. et al., Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach, Clinical Chemistry 44(2): 388-400 (1998).
Huston et al., Protein engineering of antibody binding sties: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced inEscherichia coli, Proc. Natl. Acad. Sci. USA, 85: 5879-5883 (Aug. 1998).
Li et al., New Synthesis and Characterization of (+)-Lysergic Acid Diethylamide (LDS) Dervatives and the Development of a Microparticle-Based Immunoassay for the Detection of LSD and its Metabolites, Bioconjugate Chem., 8:896-905 (1997).
Nieto, Pharmacodynamics of high-dose chemotherapy, Current Drug Metabolism 2: pp. 53-66, 2001.
Salamone et al., A Non-Cnannabinoid Immunogen Used to Elicit Antibodies with Broad Cross-Reactivity to Cannabinoid Metabolites, J. Forensic Sciences, 821-826 (Jul. 1998).
Wei X, McLeod HL, McMurrough J, Gonzalez FJ, Fernandez-Salguero P, Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity, J Clin. Invest. Aug. 1, 1996; 98(3): 610-615.
Wu et al., Synthesis of New d-Propoxphene Derivatives and the Development of a Micropartcile-Based Immunoassasy for the Detection of Propoxphene and Norpropoxyphene, Bioconjugate Chem., 8:385-390 (1997).
Courtney Jodi Blake
Salamone Salvatore J.
Stocker Dennis
Haq Shafiqul
Le Long V.
LandOfFree
5-Fluoro-uracil immunoassay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-Fluoro-uracil immunoassay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Fluoro-uracil immunoassay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3793272